Buprenorphine 2 MG Naloxone 0.5 MG Sublingual Tablet
1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablets contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and are indicated for the maintenance treatment of opioid dependence. ( 1 ). Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )
hi-tech pharmacal co. inc.
ROUND WHITE N2 arrow
N2 arrow ROUND WHITE
Related Pills
buprenorphine 8 mg naloxone 2 mg
hi-tech pharmacal co. inc.
buprenorphine and naloxone buprenorphine hydrochloride and naloxone hydrochloride tablet
hi-tech pharmacal co. inc.
Buprenorphine 2 MG Naloxone 0.5 MG Sublingual Tablet
hi-tech pharmacal co. inc.
buprenorphine and naloxone buprenorphine hydrochloride and naloxone hydrochloride tablet
hi-tech pharmacal co. inc.
buprenorphine and naloxone buprenorphine hydrochloride and naloxone hydrochloride tablet
hi-tech pharmacal co. inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED / STORAGE AND HANDLING Buprenorphine and Naloxone Sublingual Tablets are available as follows: 2mg/0.5mg -white to off-white, round, biconvex uncoated tablet, debossed with a “↑” logo on one side and an "N2" on the other side. Tablets are supplied in bottles of 30 (NDC 50383-294-93) and a blister pack of 30 (NDC 50383-294-33). 8mg/2mg -white to off-white, round, biconvex uncoated tablet, debossed with a “↑” logo on one side and "N8" on the other side. Tablets are supplied in bottles of 30 (NDC 50383-287-93) and a blister pack of 30 (NDC 50383-287-33). Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Store buprenorphine and naloxone sublingual tablets securely and dispose of properly [see Patient Counseling Information ( 17 )].
More pills like ROUND N2 arrow